Literature DB >> 24004609

Arsenite evokes IL-6 secretion, autocrine regulation of STAT3 signaling, and miR-21 expression, processes involved in the EMT and malignant transformation of human bronchial epithelial cells.

Fei Luo1, Yuan Xu, Min Ling, Yue Zhao, Wenchao Xu, Xiao Liang, Rongrong Jiang, Bairu Wang, Qian Bian, Qizhan Liu.   

Abstract

Arsenite is an established human carcinogen, and arsenite-induced inflammation contributes to malignant transformation of cells, but the molecular mechanisms by which cancers are produced remain to be established. The present results showed that, evoked by arsenite, secretion of interleukin-6 (IL-6), a pro-inflammatory cytokine, led to the activation of STAT3, a transcription activator, and to increased levels of a microRNA, miR-21. Blocking IL-6 with anti-IL-6 antibody and inhibiting STAT3 activation reduced miR-21 expression. For human bronchial epithelial cells, cultured in the presence of anti-IL-6 antibody for 3days, the arsenite-induced EMT and malignant transformation were reversed. Thus, IL-6, acting on STAT3 signaling, which up-regulates miR-21in an autocrine manner, contributes to the EMT induced by arsenite. These data define a link from inflammation to EMT in the arsenite-induced malignant transformation of HBE cells. This link, mediated through miRNAs, establishes a mechanism for arsenite-induced lung carcinogenesis.
© 2013.

Entities:  

Keywords:  Arsenite; Carcinogenesis; Epithelial–mesenchymal transition (EMT); Inflammation

Mesh:

Substances:

Year:  2013        PMID: 24004609     DOI: 10.1016/j.taap.2013.08.025

Source DB:  PubMed          Journal:  Toxicol Appl Pharmacol        ISSN: 0041-008X            Impact factor:   4.219


  24 in total

Review 1.  Arsenic-Induced Carcinogenesis: The Impact of miRNA Dysregulation.

Authors:  Ana P Ferragut Cardoso; Laila Al-Eryani; J Christopher States
Journal:  Toxicol Sci       Date:  2018-10-01       Impact factor: 4.849

Review 2.  The role of microRNAs in metal carcinogen-induced cell malignant transformation and tumorigenesis.

Authors:  Brock Humphries; Zhishan Wang; Chengfeng Yang
Journal:  Food Chem Toxicol       Date:  2016-02-20       Impact factor: 6.023

3.  Low-level arsenic causes chronic inflammation and suppresses expression of phagocytic receptors.

Authors:  Priyanka Prasad; Dona Sinha
Journal:  Environ Sci Pollut Res Int       Date:  2017-03-22       Impact factor: 4.223

4.  Epithelial-mesenchymal transition in breast epithelial cells treated with cadmium and the role of Snail.

Authors:  Zhengxi Wei; Zhongguo Shan; Zahir A Shaikh
Journal:  Toxicol Appl Pharmacol       Date:  2018-03-06       Impact factor: 4.219

5.  SHP-1 is a negative regulator of epithelial-mesenchymal transition in hepatocellular carcinoma.

Authors:  L-C Fan; C-W Shiau; W-T Tai; M-H Hung; P-Y Chu; F-S Hsieh; H Lin; H-C Yu; K-F Chen
Journal:  Oncogene       Date:  2015-01-26       Impact factor: 9.867

Review 6.  Dysregulation of microRNAs in metal-induced angiogenesis and carcinogenesis.

Authors:  Lin Wang; Ling-Zhi Liu; Bing-Hua Jiang
Journal:  Semin Cancer Biol       Date:  2021-08-21       Impact factor: 15.707

7.  Granzyme M expressed by tumor cells promotes chemoresistance and EMT in vitro and metastasis in vivo associated with STAT3 activation.

Authors:  Huiru Wang; Qing Sun; Yanhong Wu; Lin Wang; Chunxia Zhou; Wenbo Ma; Youhui Zhang; Shengdian Wang; Shuren Zhang
Journal:  Oncotarget       Date:  2015-03-20

8.  Sulindac has strong antifibrotic effects by suppressing STAT3-related miR-21.

Authors:  Xue Zhou; You-Jie Li; Shu-Yan Gao; Xiao-Zhi Wang; Ping-Yu Wang; Yun-Fei Yan; Shu-Yang Xie; Chang-Jun Lv
Journal:  J Cell Mol Med       Date:  2015-02-20       Impact factor: 5.310

Review 9.  Arsenic-induced epigenetic changes in cancer development.

Authors:  Wesley N Saintilnord; Yvonne Fondufe-Mittendorf
Journal:  Semin Cancer Biol       Date:  2021-03-30       Impact factor: 15.707

10.  Transcription Factor STAT3 as a Novel Molecular Target for Cancer Prevention.

Authors:  Ailian Xiong; Zhengduo Yang; Yicheng Shen; Jia Zhou; Qiang Shen
Journal:  Cancers (Basel)       Date:  2014-04-16       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.